Der Browser den Sie verwenden ist sehr alt.

Wir können daher nicht sicherstellen, dass jede Funktion (Gestaltung, Bilder und zusätzliche Funktionen) dieser Internetseite im vollen Umfang zur Verfügung steht. Bitte nutzen Sie eine aktuellere Browserversion.
Wir bitten um Ihr Verständnis.
Startseite > Forschung > Publikationen > Publikationen 2019

Publikationen 2019

TRIM24 as an independent prognostic biomarker for prostate cancer.
Offermann A, Roth D, Hupe MC, Hohensteiner S, Becker F, Joerg V, Carlsson J, Kuempers C, Ribbat-Idel J, Tharun L, Sailer V, Kirfel J, Svensson M, Andren O, Lubczyk V, Kuefer R, Merseburger AS, Perner S.
Urol Oncol. 2019 Jun 7. pii: S1078-1439(19)30192-9. doi: 10.1016/j.urolonc.2019.05.006. [Epub ahead of print]
PMID: 31178279

Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.
Fernández-Pello S, Hora M, Kuusk T, Tahbaz R, Dabestani S, Abu-Ghanem Y, Albiges L, Giles RH, Hofmann F, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Powles T, Staehler M, Volpe A, Ljungberg B, Bex A, Bensalah K.
Eur Urol Oncol. 2019 Jun 3. pii: S2588-9311(19)30054-9. doi: 10.1016/j.euo.2019.04.005. [Epub ahead of print] Review.
PMID: 31171501

CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer.
Frantzi M, Gomez Gomez E, Blanca Pedregosa A, Valero Rosa J, Latosinska A, Culig Z, Merseburger AS, Luque RM, Requena Tapia MJ, Mischak H, Carrasco Valiente J.
Br J Cancer. 2019 Jun;120(12):1120-1128. doi: 10.1038/s41416-019-0472-z. Epub 2019 May 16.
PMID: 31092909

[Opportunities and risks of a contemporary online presence for urologists].
Cebulla A, Marx M, Struck JP.
Aktuelle Urol. 2019 Jun 4. doi: 10.1055/a-0903-2299. [Epub ahead of print] German.
PMID: 31163463

New study suggests patients with advanced prostate cancer on androgen deprivation therapy need more dialogue with health care provider, especially around cardiovascular risk.
Merseburger A, Bro Falkenberg A, Kornilova OJ.
World J Urol. 2019 Jun;37(6):1085-1093. doi: 10.1007/s00345-018-2495-0. Epub 2018 Sep 22.
PMID: 30244335

[Molecular tumor board-urothelial cancer].
Hupe MC, Gakis G, Seiler R.
Urologe A. 2019 Jun 6. doi: 10.1007/s00120-019-0967-5. [Epub ahead of print] Review. German.
PMID: 31172245

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators.
N Engl J Med. 2019 May 31. doi: 10.1056/NEJMoa1903307. [Epub ahead of print]
PMID: 31150574

[The importance of digitalisation in urology].
Salem J, Struck JP.
Aktuelle Urol. 2019 May 15. doi: 10.1055/a-0900-3738. [Epub ahead of print] German.
PMID: 31091542

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma.
Albiges L, Powles T, Staehler M, Bensalah K, Giles RH, Hora M, Kuczyk MA, Lam TB, Ljungberg B, Marconi L, Merseburger AS, Volpe A, Abu-Ghanem Y, Dabestani S, Fernández-Pello S, Hofmann F, Kuusk T, Tahbaz R, Bex A.
Eur Urol. 2019 May 28. pii: S0302-2838(19)30426-9. doi: 10.1016/j.eururo.2019.05.022. [Epub ahead of print]
PMID: 31151678

Clinical parameters outperform molecular subtypes for predicting outcome in bladder cancer: Results from multiple cohorts including TCGA.
Morera DS, Lahorewala SS, Belew D, Ghosh S, Klaassen Z, Jordan AR, Wang J, Terris MK, Bollag RJ, Merseburger AS, Stenzl A, Soloway MS, Lokeshwar VB.
J Urol. 2019 May 21:101097JU0000000000000351. doi: 10.1097/JU.0000000000000351. [Epub ahead of print]
PMID: 31112107

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Lam TB, Marconi L, Merseburger AS, Powles T, Staehler M, Tahbaz R, Volpe A, Bex A.
Eur Urol. 2019 May;75(5):799-810. doi: 10.1016/j.eururo.2019.02.011. Epub 2019 Feb 23.
PMID: 30803729

Transient increased tumescence of the glans penis during penile erection after endovenous ablation of the great saphenous vein.
Cordes J, Zimbelmann M, Merseburger AS, Kramer M, Vonthein R, Büttner H, Recke A, Kahle BK.
J Vasc Surg Venous Lymphat Disord. 2019 May;7(3):387-391. doi: 10.1016/j.jvsv.2018.06.014. Epub 2018 Nov 23.
PMID: 30477979

[Arterioureteral fistulas in the last 10 years at the University of Lübeck].
Schneider MH, Laturnus JM, Cordes J.
Urologe A. 2019 Apr 17. doi: 10.1007/s00120-019-0923-4. [Epub ahead of print] German.
PMID: 30997547

The new ISUP 2014/WHO 2016 prostate cancer grade group system: first résumé 5 years after introduction and systemic review of the literature.
Offermann A, Hupe MC, Sailer V, Merseburger AS, Perner S.
World J Urol. 2019 Apr 2. doi: 10.1007/s00345-019-02744-4. [Epub ahead of print] Review.
PMID: 30941561

[Value of mirabegron in the treatment of overactive bladder].
Schneider MH, Struck JP.
Urologe A. 2019 Apr;58(4):432-433. doi: 10.1007/s00120-019-0916-3. German. No abstract available.
PMID: 30923855

Drittlinientherapie beim metastasierten kastrationsrefraktären Prostatakarzinom (mCRPC).
Rexer H, Hammerer P, Merseburger A.
Aktuelle Urol. 2019 Apr;50(2):144-145. doi: 10.1055/a-0832-4855. Epub 2019 Mar 21. German. No abstract available.
PMID: 30897635

Imaging in Suspected Renal-Cell Carcinoma: Systematic Review.
Vogel C, Ziegelmüller B, Ljungberg B, Bensalah K, Bex A, Canfield S, Giles RH, Hora M, Kuczyk MA, Merseburger AS, Powles T, Albiges L, Stewart F, Volpe A, Graser A, Schlemmer M, Yuan C, Lam T, Staehler M.
Clin Genitourin Cancer. 2019 Apr;17(2):e345-e355. doi: 10.1016/j.clgc.2018.07.024. Epub 2018 Aug 11.
PMID: 30528378

β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer.
Kallifatidis G, Smith DK, Morera DS, Gao J, Hennig MJ, Hoy JJ, Pearce RF, Dabke IR, Li J, Merseburger AS, Kuczyk MA, Lokeshwar VB, Lokeshwar BL.
Mol Cancer Ther. 2019 Apr;18(4):801-811. doi: 10.1158/1535-7163.MCT-18-1167. Epub 2019 Feb 20.
PMID: 30787175

Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract.
Sternberg CN, Loriot Y, James N, Choy E, Castellano D, Lopez-Rios F, Banna GL, De Giorgi U, Masini C, Bamias A, Garcia Del Muro X, Duran I, Powles T, Gamulin M, Zengerling F, Geczi L, Gedye C, de Ducla S, Fear S, Merseburger AS.
Eur Urol. 2019 Mar 22. pii: S0302-2838(19)30201-5. doi: 10.1016/j.eururo.2019.03.015. [Epub ahead of print]
PMID: 30910346

Anti-Amphiphysin-associated limbic encephalitis in a 72-year-old patient with aortic angiosarcoma.
Wagner-Altendorf TA, Wandinger KP, Frydrychowicz A, Merseburger AS, Münte TF.
BMJ Case Rep. 2019 Mar 14;12(3). pii: e226798. doi: 10.1136/bcr-2018-226798.
PMID: 30872337

The BET-inhibitor PFI-1 diminishes AR/AR-V7 signaling in prostate cancer cells.
Hupe MC, Hoda MR, Zengerling F, Perner S, Merseburger AS, Cronauer MV.
World J Urol. 2019 Feb;37(2):343-349. doi: 10.1007/s00345-018-2382-8. Epub 2018 Jun 22.
PMID: 29934670

[Medical specialist training for urologists].
Bolenz C, Michel MS, Struck JP.
Urologe A. 2019 Feb;58(2):107-108. doi: 10.1007/s00120-019-0857-x. German. No abstract available.
PMID: 30788542

[Cost effectiveness of using disposable ureterorenoscopes for diagnosis and treatment].
Hennig MJP, Knoll T, Struck JP.
Urologe A. 2019 Feb;58(2):172-174. doi: 10.1007/s00120-019-0867-8. German. No abstract available.
PMID: 30721328

[Structured training curriculum for urological residents: chances and limits].
Struck JP, Cebulla A, Ralla B, Koenig J.
Urologe A. 2019 Feb;58(2):109-113. doi: 10.1007/s00120-018-0847-4. Review. German.
PMID: 30623217

SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer.
Merseburger AS, Apolo AB, Chowdhury S, Hahn NM, Galsky MD, Milowsky MI, Petrylak D, Powles T, Quinn DI, Rosenberg JE, Siefker-Radtke A, Sonpavde G, Sternberg CN.
World J Urol. 2019 Jan;37(1):95-105. doi: 10.1007/s00345-018-2486-1. Epub 2018 Sep 20. Review.
PMID: 30238401

Role of androgen receptor splice variants, their clinical relevance and treatment options.
Wach S, Taubert H, Cronauer M.
World J Urol. 2019 Jan 19. doi: 10.1007/s00345-018-02619-0. [Epub ahead of print]
PMID: 30659302